Korro Bio, Inc. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ba43ee21-ac53-4fe8-b20b-b12cbd1f9f14/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-121.9M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-104156 |
| FY 2024 | $-91.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-040759 |
| FY 2023 | $-84.5M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-036396 |
| FY 2022 | $-59.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-036396 |
| FY 2021 | $-84.0M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003655 |
| FY 2020 | $-27.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-016117 |
| FY 2019 | $-20.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-012977 |
| FY 2018 | $-18.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-012977 |
| FY 2017 | $-16.3M | 2017-01-01 – 2017-12-31 | evidence 0001564590-20-012977 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).